What Does the Future Hold for European Biotech? Insights from Evotec’s CEO
As the CEO of Evotec, one of Europe’s largest biotech companies, Werner Lanthaler is in…
As the CEO of Evotec, one of Europe’s largest biotech companies, Werner Lanthaler is in…
Mergers, acquisitions and internal developments may add value to a company. But not all growth…
Germany has long been seen as one of the flourishing life sciences hubs in Europe.…
Structural analysis of drug-target interactions is a valuable tool to optimize new drugs for efficiency…
Here’s the list of the European biotech companies, both public and private, that are worth…
Imagine you work for a biotech startup, targeting new molecular pathways to develop innovative treatments.…
The successful development of drug candidates is a pivotal goal of today’s biopharmaceutical industry. However,…
Evotec has entered into a collaboration with Celgene to identify new therapeutics in oncology with…
Evotec will be getting over 10 assets, €60M upfront and about 100 scientists from Sanofi's…
The discovery and subsequent development of more effective and safer new medicines remains a key…
Christmas might have passed, but we have more videos for you to watch on a…
I talked with Werner Lanthaler, CEO of Evotec, during Bio Europe 2017 to ask him…